Abstract
Over the last decades, the scientific interest in chemistry and pharmacology of cannabinoids has increased. Most attention has focused on Δ9-tetrahydrocannabinol (Δ9-THC) as it is the psychoactive constituent of Cannabis sativa (C. sativa). However, in previous years, the focus of interest in the second plant constituent with non-psychotropic properties, cannabidiol (CBD) has been enhanced. Recently, several groups have investigated the pharmacological properties of CBD with significant findings; furthermore, this compound has raised promising pharmacological properties as a wake-inducing drug. In the current review, we will provide experimental evidence regarding the potential role of CBD as a wake-inducing drug.
Keywords: Dopamine, hypothalamus, marijuana, sleep, sleepiness.
Current Neuropharmacology
Title:Potential Effects of Cannabidiol as a Wake-Promoting Agent
Volume: 12 Issue: 3
Author(s): Eric Murillo-Rodriguez, Andrea Sarro-Ramirez, Daniel Sanchez, Stephanie Mijangos-Moreno, Alma Tejeda-Padron, Alwin Poot-Ake, Khalil Guzman, Elda Pacheco-Pantoja and Oscar Arias-Carrion
Affiliation:
Keywords: Dopamine, hypothalamus, marijuana, sleep, sleepiness.
Abstract: Over the last decades, the scientific interest in chemistry and pharmacology of cannabinoids has increased. Most attention has focused on Δ9-tetrahydrocannabinol (Δ9-THC) as it is the psychoactive constituent of Cannabis sativa (C. sativa). However, in previous years, the focus of interest in the second plant constituent with non-psychotropic properties, cannabidiol (CBD) has been enhanced. Recently, several groups have investigated the pharmacological properties of CBD with significant findings; furthermore, this compound has raised promising pharmacological properties as a wake-inducing drug. In the current review, we will provide experimental evidence regarding the potential role of CBD as a wake-inducing drug.
Export Options
About this article
Cite this article as:
Murillo-Rodriguez Eric, Sarro-Ramirez Andrea, Sanchez Daniel, Mijangos-Moreno Stephanie, Tejeda-Padron Alma, Poot-Ake Alwin, Guzman Khalil, Pacheco-Pantoja Elda and Arias-Carrion Oscar, Potential Effects of Cannabidiol as a Wake-Promoting Agent, Current Neuropharmacology 2014; 12 (3) . https://dx.doi.org/10.2174/1570159X11666131204235805
DOI https://dx.doi.org/10.2174/1570159X11666131204235805 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phytochemicals in the Treatment of Alzheimer’s Disease: A Systematic Review
Current Drug Targets Withdrawal Notice: Neuroprotective Effect of Lithospermum officinale callus Extract on Inflamed Primary Microglial Cells
Current Pharmaceutical Biotechnology Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Aging Science Improving the Hsp90 Inhibitors Containing 4-(2,4-Dihydroxyphenyl)-1,2,3-thiadiazole Scaffold: Synthesis, Affinity and Effect on Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Ionotropic Glutamate Receptors & CNS Disorders
CNS & Neurological Disorders - Drug Targets Effects of Memantine on Event-Related Potentials in Alzheimer’s Disease Under Donepezil Treatment
Neuroscience and Biomedical Engineering (Discontinued) A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Editorial: Exciting Progresses in Stem Cell and Neural Stem Cell Research
Current Molecular Medicine Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Biosynthesis of Flavin Cofactors in Man: Implications in Health and Disease
Current Pharmaceutical Design NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets State Dissociation, Human Behavior, and Consciousness
Current Topics in Medicinal Chemistry Distribution of Quercetin in Different Organs of Male Sprague Dawley Rats Under Hypoxia: A High-Performance Thin Layer Chromatography Approach
Current Chromatography Potential Beneficial Effects of Marine Peptide on Human Neuron Health
Current Protein & Peptide Science Pharmacomimetics of Exercise: Novel Approaches for Hippocampally- Targeted Neuroprotective Agents
Current Medicinal Chemistry Neurobiology of Sleep Disturbances in Neurodegenerative Disorders
Current Pharmaceutical Design Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders
Current Molecular Medicine GPCR Binding Technologies: An Overview
Current Topics in Medicinal Chemistry